Biohaven Pharmaceutical Holding Co Ltd.

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Quarterly Report for period ending 2021-06-30

Quarterly Report for period ending 2021-03-31

Annual Report for period ending 2020-12-31

Quarterly Report for period ending 2020-09-30

Quarterly Report for period ending 2020-06-30

Quarterly Report for period ending 2020-03-31

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Order Granting Confidential Treatment

Order Granting Confidential Treatment

Notice of Effectiveness

Clark George C.: Statement of changes in beneficial ownership of securities

CHILDS JOHN W: Statement of changes in beneficial ownership of securities

Buten Matthew: Statement of changes in beneficial ownership of securities

GREGORY JULIA P: Statement of changes in beneficial ownership of securities

Stock Elyse: Statement of changes in beneficial ownership of securities

Mehta Kishan: Statement of changes in beneficial ownership of securities

HUGIN ROBERT J: Statement of changes in beneficial ownership of securities

Gentile Kimberly: Statement of changes in beneficial ownership of securities

Antonijevic Irina: Statement of changes in beneficial ownership of securities

Conway Charles: Statement of changes in beneficial ownership of securities

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Prospectus filed pursuant to Rule 424(b)(7)

Prospectus filed pursuant to Rule 424(b)(7)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(7)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statement relating to a merger, acquisition, or disposition

Preliminary revised proxy soliciting materials

Preliminary proxy statement relating to a merger, acquisition, or disposition

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.